跳至主要内容
临床试验/IRCT20211021052828N1
IRCT20211021052828N1尚未招募1 期

Evaluating the effects of allogeneic transplantation of umbilical cord- derived mesenchymal stem cells combination with in vitro activation (IVA) technique on improvement of ovarian function and fertility outcomes in women with premature ovarian failure (POF)- Clinical trials phase I

Mehr medical Institute0 个研究点目标入组 10 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
Female

入选标准

  • Normal karyotyping female
  • Diagnosed with Premature Ovarian Failure: Serum FSH > 20 IU/l, AMH < 0.3 ng /mL
  • Agree to sign the designed consent for the study
  • women aged 18 to 40 years old

排除标准

  • Thyroid dysfunction
  • Immunological Conditions
  • Past history of malignancy/cemotherapy/radiotherapy
  • Infectious diseases: HIV+, hepatitis B+, C+
  • Abnormal karyotype
  • Previous surgical management of ovarian pathology
  • Severe endometriosis
  • Breast cancer, ovarian cancer
  • Severe pulmonary, kidney and hematological disease, diabetes (type I,II), ...
  • Severe anemia (Hemoglobin <8 g/dL)

研究者

发起方
Mehr medical Institute

相似试验